Home › Narcolepsy › Florida
Narcolepsy clinical trials in Florida
7 studies for Narcolepsy are looking for participants at sites in Florida.
Cities in Florida
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Brandon, Florida, Brandon
- Miami, Florida, Miami
- Miami, Florida, Miami
- and 4 more
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Sep 11, 2026 · NCT07598708A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07455383A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- PharmaDev Clinical Research Institute, LLC, Miami
- Florida Pediatric Sleep Disorders Institute, Winter Park
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07675135A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT06767683A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
- Takeda Site 14, Miami
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jun 29, 2026 · NCT07633301A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
- Meris Clinical Research-310 Oakfield Dr, Brandon
- Hope Research Network Trials -6500 NW 77th CT, Medley
- Vitaly Clinical Research LLC, Miami
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT07493265A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Miami, Florida, Miami
- Orlando, Florida, Orlando
- Winter Park, FL, Winter Park
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 16, 2026 · NCT07096674From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.